Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma

Clinical trial NCT07518654 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07518654
Sponsor: Michel Duval
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Leukaemia (Acute Lymphoblastic)Leukaemia (Acute Myeloid)Neuroblastoma Neuroblastoma, Metastatic Leukaemia, Lymphoblastic, Acute Leukemia Acute Myeloid Leukemia (Both ALL and AML)Leukemia Acute Myeloid - AML Hematopoetic Stem Cell Transplantation Hematopoetic Stem Cell Transplant

Start date: 2026-05-01
Primary completion: 2029-05-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.